City

Guangzhou (1)

Condition

Monoclonal Gammopathies (2)

M-protein (1)

Multiple Myeloma (1)

Obesity (1)

Overweight (1)

Overall Status

Recruiting (1)

Withdrawn (1)

Sign in for free

Phase

phase 4 (1)

Sponsor

University of Miami (1)

Zhujiang Hospital (1)

Collaborator

National Natural Science Foundation of China (1)

Intervention

liraglutide (1)

observational studies, no intervention (1)

Study Documents

Intervention Type

drug (1)

other (1)

Funder Type

Other (2)

Study Type

Interventional (1)

Observational [Patient Registry] (1)

monoclonal gammopathies

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Monoclonal Gammopathies, Multiple Myeloma, M-protein Trial in Guangzhou (Observational studies, no intervention)

Recruiting

Monoclonal Gammopathies
+2 more

Observational studies, no intervention

Guangzhou, Guangdong, China

Zhujiang Hospital of Southern Medical University

Jan 6, 2023

Monoclonal Gammopathies, Overweight, Obesity Trial (Liraglutide)

Withdrawn

Monoclonal Gammopathies
+2 more

Liraglutide

(no location specified)

Sep 17, 2020